CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
Patrick Wagner(Cornell University), Anjali Saqi(Columbia University Irving Medical Center), Madeline Vazquez(NewYork–Presbyterian Hospital), Paul C. Lee(Cornell University), Gabriel Sica(Emory University), Tatiana Rengifo(NewYork–Presbyterian Hospital), Nasser K. Altorki(Cornell University), Jeffrey L. Port(Cornell University), Danish Meherally(NewYork–Presbyterian Hospital), Yi Fang Liu(NewYork–Presbyterian Hospital), Elizabeth Hyjek(University of Chicago), Subroto Paul(NewYork–Presbyterian Hospital), Paul A. Chadwick(NewYork–Presbyterian Hospital)
Cited by 107
Related Papers
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899